Previous close | 17.00 |
Open | 17.62 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 180.00 |
Expiry date | 2024-09-20 |
Day's range | 17.00 - 17.62 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Unraveling the Financial and Strategic Position of ALNY in the Biopharmaceutical Arena
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alnylam (ALNY) delivered earnings and revenue surprises of 78.67% and 17.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?